- - CEO Nasrat Say $160 million - - Split = $8
Post# of 2146
(Total Views: 962)
Posted On: 12/01/2019 1:07:37 PM
- - CEO Nasrat Say $160 million - -
Split = $80 Million
$40 Million To Make Product
$40 Million Profit To ELTP
So Gross to ELTP is $80 Million now add the $20 Million = $100 Million Gross.
Company is 400% Larger on Top Of Having Recently Doubled In Size.
Quote Nasrat:
“The last SunGen that was filed in May was an extended-release CNS stimulant that we co-developed with our partner SunGen. The branded and generic sales of this product are approximately $1.6 BILLION and there are currently just FOUR meanufacturers which includes the branded and its authorized generics.“
“ This is an outstanding product for us once we get an approval because we will be the fifth in this arena, and even if there were more people than that and we've got just 10% of that market, that's $160 million, a $160 million in revenues will do wonders to Elite stock. Even if we cut it in half between us and SunGen and you take out the actual cost which is another half and walk away with only $40 million, that will take our market cap from 80 million which is today to $800 million with one product only."
Split = $80 Million
$40 Million To Make Product
$40 Million Profit To ELTP
So Gross to ELTP is $80 Million now add the $20 Million = $100 Million Gross.
Company is 400% Larger on Top Of Having Recently Doubled In Size.
Quote Nasrat:
“The last SunGen that was filed in May was an extended-release CNS stimulant that we co-developed with our partner SunGen. The branded and generic sales of this product are approximately $1.6 BILLION and there are currently just FOUR meanufacturers which includes the branded and its authorized generics.“
“ This is an outstanding product for us once we get an approval because we will be the fifth in this arena, and even if there were more people than that and we've got just 10% of that market, that's $160 million, a $160 million in revenues will do wonders to Elite stock. Even if we cut it in half between us and SunGen and you take out the actual cost which is another half and walk away with only $40 million, that will take our market cap from 80 million which is today to $800 million with one product only."
(0)
(0)Elite Pharmaceuticals Inc (ELTP) Stock Research Links
Scroll down for more posts ▼